Replies to post #157899 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

One thing we do not know is how many patients are in fact left in the extension trials. I have asked IR that question multiple times with no luck.

I am hoping that information may be revealed in connection with AAIC conference. If not we may have to wait until November when the last patient of however many crossed 3 years of A2-73 dosing.

[tredenwater2]

Thanks Falconer for the elaboration on these 2 theories. I am excited as ever to see the unveiling of the data on the 25 that continued in the PH2a trial and of course the new trials. Im still young enough that I have 10+ years that I would need to take anything on the market, God willing, but me and my wife always marval at why anyone would want to take a drug that has side effects that outweigh the original symptom. Must be the well targeted commercial showing a smiling, gallivanting, playful adult that gets people to ask their doctors about taking them.


Tred